Historical Context & Motivation
The study of inflammation stretches back to antiquity, when Roman physician Aulus Cornelius Celsus first catalogued the four cardinal signs of inflammation—rubor (redness), tumor (swelling), calor (heat), and dolor (pain)—in the first century CE. For nearly two millennia, clinicians recognized these signs without understanding the cellular and molecular machinery responsible for them. The emergence of microscopy, germ theory, and immunochemistry gradually revealed that inflammation, fever, and the complement system are interlocking arms of innate immunity, the body's rapid, non-specific first line of defense against infection and tissue damage.
A central question has driven immunology for over a century: how does the body mount an immediate, coordinated defense against pathogens it has never encountered before? The answer lies in the interplay of inflammation, fever, and complement—three mechanisms that detect danger signals, recruit immune cells, and create hostile conditions for microbial invaders, all within minutes to hours of initial exposure. This lesson examines each mechanism in detail, then integrates them into a unified model of innate immune defense.
Core Principles & Definitions
Inflammation, fever, and complement share a common purpose—defending the body against threats—but each accomplishes this through distinct cellular and molecular strategies. Before exploring their mechanisms in depth, it is essential to establish the foundational concepts that unite these three innate immune responses. Together, they illustrate a principle that recurs throughout physiology: rapid, non-specific defense mechanisms buy time for the slower, antigen-specific adaptive immune system to mount a tailored response.
Inflammation
Fever (Pyrexia)
Complement System
Pattern Recognition
The Inflammatory Response — Visual Explanation
The inflammatory response unfolds in a predictable sequence of vascular and cellular events. When tissue is injured or invaded by pathogens, resident sentinel cells—primarily macrophages and mast cells—detect PAMPs and DAMPs through their TLRs and release chemical mediators such as histamine, prostaglandins, and cytokines (including IL-1, IL-6, and TNF-α). These mediators trigger arteriolar vasodilation, increase capillary permeability, and establish a chemotactic gradient that guides circulating neutrophils and monocytes toward the site of damage. The diagram below illustrates this cascade from initial injury through leukocyte extravasation.
Observe in the diagram that the process is sequential yet rapid. Within minutes of injury, histamine from mast cells causes local arteriolar vasodilation and venular permeability changes, producing the hallmark redness and swelling. Cytokines released by tissue macrophages upregulate selectins and integrins on the endothelial surface, which act as molecular 'Velcro' to capture fast-flowing neutrophils from the bloodstream—a process called margination. Once adhered, neutrophils squeeze between endothelial cells via diapedesis and migrate along the chemotactic gradient of complement fragments (C3a, C5a) and bacterial products to reach the infection site. This orchestrated recruitment ensures that the immune system's most abundant phagocytes arrive precisely where they are needed.
Mechanism of Fever
While inflammation is primarily a localized response, fever represents a systemic escalation of innate defense. Fever is not simply an elevated body temperature; it is a tightly regulated upward reset of the hypothalamic thermoregulatory set point, orchestrated by signaling molecules called pyrogens. Pyrogens fall into two categories: exogenous pyrogens (microbial products such as lipopolysaccharide from Gram-negative bacteria) and endogenous pyrogens (host cytokines—primarily IL-1, IL-6, and TNF-α—released by activated macrophages and other leukocytes). Exogenous pyrogens trigger the release of endogenous pyrogens, which then travel through the bloodstream to the preoptic area of the hypothalamus.
The Prostaglandin E₂ Pathway
When endogenous pyrogens reach the hypothalamus, they stimulate the enzyme cyclooxygenase-2 (COX-2) in perivascular cells of the blood-brain barrier, catalyzing the synthesis of prostaglandin E₂ (PGE₂). PGE₂ binds to EP3 receptors on thermosensitive neurons, raising the thermoregulatory set point. The body then perceives its current temperature as 'too cold' and activates heat-generating mechanisms—vasoconstriction to reduce heat loss, shivering thermogenesis to generate metabolic heat, and behavioral responses such as seeking warmth and curling up. This is why patients with rising fevers often feel chills: the set point has shifted upward, but core temperature has not yet caught up.
Benefits and Risks of Fever
- Enhanced immune function: Moderate fever (38–39 °C) increases neutrophil migration, macrophage phagocytic activity, and lymphocyte proliferation.
- Inhibited pathogen replication: Many bacteria and viruses replicate optimally at 37 °C; even a 1–2 °C rise can reduce their growth rate significantly.
- Acute-phase protein synthesis: The liver increases production of C-reactive protein (CRP), fibrinogen, and complement components during fever.
- Danger zone: Temperatures above 41 °C (hyperpyrexia) risk protein denaturation, seizures, and multi-organ failure—fever must be self-limiting.
Fever resolution, or defervescence, occurs when pyrogen levels decline as the infection is controlled. The set point returns to normal, and the body now perceives itself as 'too hot,' triggering vasodilation and sweating to dissipate excess heat. This is why the 'breaking' of a fever is accompanied by profuse perspiration.
The Complement System — Pathways & Outcomes
The complement system consists of roughly 30 plasma proteins, most synthesized by the liver, that circulate in inactive (zymogen) forms. Upon activation, they undergo sequential proteolytic cleavage in a cascade that amplifies the signal enormously—a single initiating event can generate millions of effector molecules within minutes. Three distinct pathways converge on a common step: the cleavage of C3 into C3a and C3b. From this convergence point, the cascade proceeds to form the membrane attack complex and release potent inflammatory mediators.
| Pathway | Trigger | Key Components | Innate or Adaptive? |
|---|---|---|---|
| Classical | Antigen-antibody (IgG/IgM) complexes bind C1q | C1q, C1r, C1s, C4, C2 | Bridges adaptive → innate |
| Lectin | Mannose-binding lectin (MBL) or ficolins bind carbohydrates on pathogen surfaces | MBL, MASP-1/2, C4, C2 | Innate |
| Alternative | Spontaneous hydrolysis of C3 (tick-over); amplified on surfaces lacking regulatory proteins | C3, Factor B, Factor D, Properdin | Innate |
A critical feature of complement regulation is that host cells express complement regulatory proteins such as decay-accelerating factor (DAF/CD55), membrane cofactor protein (MCP/CD46), and protectin (CD59) on their surfaces. These molecules accelerate the degradation of C3 convertase or block MAC assembly, ensuring that the destructive power of complement is directed at pathogens and foreign cells rather than healthy host tissue. Deficiencies in these regulators underlie diseases such as paroxysmal nocturnal hemoglobinuria (PNH), in which host red blood cells are lysed by uncontrolled complement activation.
Worked Example — Tracing an Innate Immune Response
Consider the following clinical scenario: a patient sustains a deep splinter wound on the sole of the foot while walking barefoot outdoors. The wound is contaminated with soil bacteria, including Gram-negative species that possess lipopolysaccharide (LPS) in their outer membranes. Let us trace the innate immune response step by step, integrating inflammation, complement activation, and fever.
Comparing Innate Defense Mechanisms
Although inflammation, fever, and complement all serve defensive functions, they differ substantially in scope, speed, specificity, and potential for causing host damage. Understanding these distinctions is essential for clinical reasoning—many pathologies arise not from immune failure but from excessive or dysregulated activation of these very systems.
| Feature | Inflammation | Fever | Complement |
|---|---|---|---|
| Scope | Local (acute); can become systemic (SIRS/sepsis) | Systemic (whole-body thermoregulatory reset) | Local (at pathogen surface); systemic effects via anaphylatoxins |
| Speed of onset | Seconds to minutes | Minutes to hours | Seconds (alternative) to hours (classical) |
| Key mediators | Histamine, prostaglandins, IL-1, TNF-α, leukotrienes | IL-1, IL-6, TNF-α → PGE₂ | C3a, C3b, C5a, C5b-9 (MAC) |
| Primary function | Contain damage, recruit leukocytes, initiate repair | Inhibit microbial growth, enhance immune cell function | Opsonize, lyse, amplify inflammation, recruit phagocytes |
| Pathological excess | Chronic inflammation (e.g., rheumatoid arthritis) | Hyperpyrexia (>41 °C), febrile seizures | PNH, complement-mediated hemolytic uremic syndrome (HUS) |
| Pharmacological targets | NSAIDs (COX inhibitors), corticosteroids, anti-TNF biologics | Antipyretics (aspirin, acetaminophen, ibuprofen) | Eculizumab (anti-C5 monoclonal antibody) |
Connections to Adaptive Immunity & Advanced Topics
Innate immunity does not operate in isolation—it fundamentally shapes and activates the adaptive immune response. The bridge between innate and adaptive immunity is largely constructed by dendritic cells, which are activated during inflammation, process antigens at the site of infection, and migrate to regional lymph nodes where they present peptide-MHC complexes to naïve T cells. The cytokine milieu established by innate inflammation (e.g., IL-12, IL-6, type I interferons) determines which subset of T helper cells differentiates—Th1, Th2, or Th17—thereby shaping the character of the subsequent adaptive response. Complement fragment C3d, covalently bound to antigen, also lowers the activation threshold for B cells by cross-linking CR2 (CD21) with the B cell receptor, acting as a molecular adjuvant.
| Feature | Innate Immunity | Adaptive Immunity |
|---|---|---|
| Response time | Immediate (minutes to hours) | Delayed (days to weeks for primary response) |
| Specificity | Broad (PAMPs/DAMPs); limited receptor diversity (~10³ PRRs) | Highly specific (unique epitopes); vast receptor diversity (~10¹¹ TCRs/BCRs) |
| Memory | No classical memory (though 'trained immunity' is now recognized) | Immunological memory via memory T and B cells |
| Key effectors | Neutrophils, macrophages, NK cells, complement, cytokines | T cells (CD4⁺, CD8⁺), B cells, antibodies |
| Complement link | Alternative and lectin pathways are fully innate | Classical pathway is activated by antibodies (IgG, IgM) |
Practice Problems
Lesson Summary
The body's innate immune defenses operate through three interlocking systems. Inflammation is a localized vascular and cellular response initiated when sentinel cells detect PAMPs and DAMPs via pattern recognition receptors. Vasodilation, increased capillary permeability, and leukocyte extravasation (margination → diapedesis → chemotaxis) deliver neutrophils and plasma proteins to the site of injury, producing the cardinal signs of rubor, tumor, calor, dolor, and functio laesa. Fever is a systemic response in which endogenous pyrogens (IL-1, IL-6, TNF-α) drive PGE₂ synthesis in the hypothalamus, resetting the thermoregulatory set point upward to enhance immune function and inhibit pathogen growth.
The complement system comprises ~30 plasma proteins activated via three pathways—classical (antibody-mediated), lectin (mannose recognition), and alternative (spontaneous C3 hydrolysis)—all converging on C3 convertase. Key outcomes include opsonization (C3b), inflammation amplification (C3a/C5a anaphylatoxins), and direct pathogen lysis via the membrane attack complex (MAC). Host cells are protected by regulatory proteins (CD55, CD59). Together, these three innate mechanisms contain and eliminate threats within hours, while simultaneously activating adaptive immunity for long-term protection.